Clinical Trial Update: A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD [Phase 2]

View source ↗

Summary

A Phase 2A trial evaluating FMX-8 for anemia in patients with end-stage renal disease on hemodialysis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Disease
• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• FMX-8

Snippet

Sponsor: FerruMax Pharmaceuticals, Inc. | Conditions: Anemia of Chronic Disease | Phase 2 | Status: TERMINATED